| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020420 |
| Receipt No. | R000023584 |
| Official scientific title of the study | Study of additive effect of citrus juice fermented with lactic bacteria to sublingual immunotherapy for Japanese cedar pollinosis (Randomized placebo controlled double blind clinical study) |
| Date of disclosure of the study information | 2016/01/03 |
| Last modified on | 2018/07/05 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Study of additive effect of citrus juice fermented with lactic bacteria to sublingual immunotherapy for Japanese cedar pollinosis (Randomized placebo controlled double blind clinical study) | |
| Title of the study (Brief title) | Study of additive effect of citrus juice fermented with lactic bacteria to sublingual immunotherapy | |
| Region |
|
|
| Condition | ||
| Condition | Japanese cedar pollinosis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine an additive effect of the citrous juice fermented with lactic bacteria (YIT0132) to sublingual immunotherapy for Japanese cedar pollinosis. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Comparison of the total nosal symptom medication score converted from a nasal allergy diary in peak of cedar pollen scattering |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Taking 125ml of citrus juice fermented with lactic bacteria (YIT0132) every day for 3 month around cedar pollen scattering period. | |
| Interventions/Control_2 | Taking 125ml of placebo every day for 3 month around cedar pollen scattering period. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with Japanese cedar pollinosis who is being treated with sublingual immunotherapy | |||
| Key exclusion criteria | 1) Allergy to the intervention drink or citrus juice
2) Diabetes mellitus (HbA1c more than 6.0) 3) Pregnant women and those at risk of pregnancy 4) Women who are planning pregnancy 5) Lactating woman 6) Patients treated with anti-allergic drugs within 2 week of screening 7) The patients who the doctor judged inappropriate for the study 8) Severe asthma 9) Malignant disease or immune disorder |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshitaka Okamoto |
| Organization | Chiba University Graduate School |
| Division name | Department of Otorhinolaryngology |
| Address | 1-8-1 Inohana,Chuo-ku Chiba 260-8677 |
| TEL | 043-222-7171 |
| yokamoto@faculty.chiba-u.jp | |
| Public contact | |
| Name of contact person | Syuji Yonekura |
| Organization | Chiba University Graduate School |
| Division name | Department of Otorhinolaryngology |
| Address | 1-8-1 Inohana,Chuo-ku Chiba 260-8677 |
| TEL | 043-222-7171 |
| Homepage URL | |
| syonekura@faculty.chiba-u.jp | |
| Sponsor | |
| Institute | Department of Otorhinolaryngology in Ciba University Graduate School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Health, Labour and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023584 |